Statement on Senators’ Probe of Opioid Overdose Treatment Price Spikes

“The pharmaceutical industry’s habit of hiking prices on life-saving medications is appalling. Our campaign has been active in drawing attention to the price spikes on naloxone and we welcome this bipartisan effort to expose pharma’s price gouging tactics.”

Read more

American Gastroenterological Association Joins Campaign for Sustainable Rx Pricing

The American Gastroenterological Association announced today that it has joined the Campaign for Sustainable Rx Pricing, a broad-based campaign working to curb rising drug costs. AGA, which has 16,000 members involved in all aspects of gastroenterology around the globe, adds its voice to the hospitals, physicians, pharmacists, nurses, health plans, patients, and employers already promoting CSRxP’s solutions of transparency, competition, and value in the prescription drug market.

Read more

Rising Prescription Drug Prices: Can We Keep Up?

We need to move toward market-based solutions to increase transparency, promote competition, and enhance value. For the millions of Americans living with chronic conditions – including allergies and arthritis, these solutions cannot come soon enough.

Read more

John Rother on Rising Price of Opioid Overdose Treatment

“Drug companies seem to be taking advantage of increased demand for Naloxone during this public health crisis by raising the price of a literally lifesaving medication,” said John Rother, executive director of the Campaign for Sustainable Rx Pricing.

Read more